Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
US7566722B2 · kind B2 · utility
0Cited by
16References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2007 |
| Grant date | Jul 28, 2009 |
| Priority date | — |
| Expiry date | Oct 31, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof:wherein R1 and R2 are as defined herein, and their methods of preparation and use as ADP inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.